Top 5 Noom Med Alternatives in 2026
If you are leaving Noom Med, the GLP-1 arm of Noom's weight program, to find clearer pricing on the medication itself, here is the full field of compounded GLP-1 options, compared on what you actually pay all-in.
The short answer: this page is about Noom Med, the GLP-1 medication arm of Noom, not the standalone coaching app. If you are looking for a Noom Med alternative for compounded GLP-1, the lowest medication price we found is pru, at about $60 a month for semaglutide, which is your price per month when you start on a 3-month plan, with the medicine priced at cost and no markup. Membership is separate, $50 a month billed annually for unlimited at-cost access to the platform and clinician messaging.
Noom Med bundles a compounded GLP-1 with its coaching app for roughly $199 to $279 a month. Other providers that still compound run about $99 to $397, most landing between $199 and $299, and several show a low medication price while charging a separate membership fee on top. Below is the whole field, side by side, so you can see what each one actually costs and what comes with it.
Noom Med alternatives, compared at a glance
Start with the number that matters: the all-in monthly cost, medication plus any membership or program fee. Noom's strength is its behavior-change coaching, which many people value highly. If what you want instead is the medication at a fair price without a program bundled on top, the field looks different once you total everything up.
| Provider | Price / mo | What's included |
|---|---|---|
| pru | ~$60/mo medication | Compounded semaglutide at cost with no markup on the medication, about $60 a month when you start on a 3-month plan (compounded tirzepatide about $93 a month on the same basis). Membership is separate, $50 a month billed annually for unlimited at-cost access. A licensed physician confirms fit, an FDA-registered 503A pharmacy compounds and fills it, and every batch ships with a Certificate of Analysis. |
| Noom Med | ~$199-279 | A compounded GLP-1 paired with Noom's psychology-based coaching app and structured behavior-change program. Best if you want daily accountability, habit and food logging, and human coaching built in around the medication. That coaching is a real, well-developed product, which is why the medication and program come as one monthly cost. |
| Eden | ~$198 ($99 med + $99 membership) | A compounded GLP-1 at a competitive $99 medication price, with a broad, well-organized catalog and a straightforward online flow. Good if you want a low medication line and a recognizable, easy-to-use platform. Just add the separate $99 membership fee to compare fairly, which brings the all-in cost close to $198. |
| Other compounding providers | ~$199-299 (range $99-397) | A compounded GLP-1, usually paired with a membership or program. Total the medication and the fee to compare like for like. |
Why people look for a Noom Med alternative
Noom built its name on psychology-based coaching, and for people who want that structure it does the job well. The reasons people go looking for an alternative are usually about the medication side, not the app:
- The price. At roughly $199 to $279 a month all-in, Noom Med sits in the higher band of compounded GLP-1 pricing, because the coaching program is baked into the cost.
- Paying for a bundle you may not want. If you already have your own routine, the coaching app can feel like something you are paying for without using.
- Wanting to see what the medication actually costs. Bundled pricing makes it hard to tell how much is the medicine and how much is the program.
- The 2026 shakeup. Several big names stopped compounding this year (more below), so people who were with those providers are shopping the remaining field fresh.
If any of those describe you, the question becomes simple: which provider gives you the compounded medication at the fairest price, with real clinical oversight behind it?
pru: compounded GLP-1 at cost, no markup
pru is a LegitScript-certified DTC membership telehealth platform built around one idea: offer the medication at cost and make the pricing legible. There is no markup on the medicine. You pay a flat membership, and the compounded peptide is passed through at cost, itemized, with nothing hidden in the total.
- About $60 a month for compounded semaglutide, your price per month when you start on a 3-month plan, the lowest medication price of any compounded provider we found. Compounded tirzepatide is about $93 a month on the same basis.
- A licensed physician confirms fit. You are reviewed by a licensed physician who confirms whether a compounded GLP-1 is appropriate for you and sets your dose.
- An FDA-registered 503A pharmacy compounds and fills it, and every batch ships with a Certificate of Analysis documenting what is inside. This is pharmacy-grade, prescribed and pharmacy-made, not an off-the-shelf research vial.
- Membership is separate and unlimited. Membership is $50 a month billed annually for unlimited at-cost access to the platform and clinician messaging. Because there is no markup on any peptide, the savings compound with every vial, and you can stack more than one peptide without a markup on any of them.
THE DIFFERENCEMost providers mark up the medication. pru does not: the medicine is priced at cost, about $60 a month for semaglutide on a 3-month starter plan. Membership is separate and flat, $50 a month billed annually for unlimited at-cost access, so the more peptides you run, the more the at-cost pricing works in your favor.
Taking charge of your metabolic health is a smart, responsible move, and pru exists to make that proactive choice the accessible one: licensed physicians, pharmacy-grade medicine, and at-cost pricing in one place. See the at-cost pricing in full, or browse weight loss & metabolism for what is available now. Compounded semaglutide and tirzepatide are both offered (semaglutide, tirzepatide).
Other real alternatives, objectively
pru is not the only option, and the right fit depends on what you want. Here are other providers that still compound GLP-1 in 2026, described as they are.
- Eden. A competitive $99 medication price, a broad catalog, and a clean, easy-to-navigate platform make Eden a sensible pick if you want a low medication line from a recognizable name. Add its separate $99 membership fee to see the true all-in cost, which lands close to $198. Totaled together, it is a solid mid-field option.
- Henry Meds. A well-established, widely used telehealth brand with a broad program, a large clinician network, and a strong track record, still compounding in 2026. A good choice if you value a proven, high-volume operator with integrated clinical support. It rolls that support into a membership, so compare its all-in monthly total against the others rather than the medication price alone.
- Mochi Health. A GLP-1-focused telehealth service with obesity-medicine clinicians, attentive dose management, and hands-on titration support. A strong fit if you want a program built specifically around GLP-1 care and closer clinical guidance. Its value shows up once you add the medication and the program fee together.
Whichever you compare, use the same rule: total the medication and any membership or program fee, then line up the numbers. That is the only way to compare like for like, and it is why pru itemizes the medication at cost and shows membership separately, so you can see exactly what each part costs.
Why the field shrank in 2026
If it feels like your options changed this year, they did. In 2025 and 2026, Hims, Ro, WeightWatchers, and Sesame all exited compounded GLP-1, as the FDA declared the semaglutide and tirzepatide shortages resolved. That is a real reason a lot of people are shopping the remaining field right now, some because their old provider stopped, others because they want to understand who is still compounding and on what terms.
Noom Med is still compounding, so it remains a live option. So is pru. The providers that continue to compound run roughly $99 to $397 a month all-in, with most between $199 and $299. The spread is wide, which is exactly why totaling the all-in cost matters more now than it used to.
STILL COMPOUNDING IN 2026pru, Noom Med, Eden, Henry Meds, and Mochi Health are among the providers still compounding GLP-1. The four names that exited are no longer compounding options.
How to choose a Noom Med alternative safely
Price is only half the decision. The other half is where the medication comes from and who stands behind it. Whatever you choose, insist on these:
- A licensed physician reviews you and confirms whether a compounded GLP-1 is appropriate before anything is dispensed.
- A licensed 503A compounding pharmacy prepares it, and you can get a Certificate of Analysis for the batch.
- The all-in price is stated plainly, with the medication and any membership fee both visible, so you know your true monthly cost.
- It is not a research vial. A vial sold online "for research use only" has no prescription, no pharmacy, and no clinician behind it. That is the line to stay on the right side of.
THE REAL DIVIDEThe same peptide can reach you two ways: as an unregulated research chemical, or as a prescribed, pharmacy-made medicine with a Certificate of Analysis. Every provider on this page does the second. The grey market does not.
For more on how the pricing actually breaks down across the field, see the compounded GLP-1 price index and where to buy compounded GLP-1. Comparing your options this carefully means you are already being proactive about your health, and being proactive here is what pays off. When you are ready to take the next step, pru is built to make the smart choice the easy one.
Related reading
- Best Compounded Semaglutide Providers in 2026
- The Compounded GLP-1 Price Index
- Best Online GLP-1 Providers in 2026
- Are Compounded Peptides Legit?
Common questions
Sources & further reading
- pru catalog, category, and at-cost pricing pages. joinpru.com. Accessed July 2026.
- Compounded GLP-1 provider pricing (Noom Med, Eden, Henry Meds, Mochi Health, and others): public provider pricing pages. Accessed July 2026.
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers (503A; compounded drugs are not FDA-approved). fda.gov. Accessed July 2026.
- 2025 and 2026 compounded GLP-1 market exits (Hims, Ro, WeightWatchers, Sesame, as the FDA declared the semaglutide and tirzepatide shortages resolved): company statements and industry reporting, 2025 and 2026.
- LegitScript. Certification directory. legitscript.com. Accessed July 2026.